116 related articles for article (PubMed ID: 17460891)
61. Preparation and characterization of anti-tenascin monoclonal antibody-streptavidin conjugates for pretargeting applications.
Foulon CF; Bigner DD; Zalutsky MR
Bioconjug Chem; 1999; 10(5):867-76. PubMed ID: 10502355
[TBL] [Abstract][Full Text] [Related]
62. [Expression and analysis of biological activity of wild-type and mutant interleukin-13 in E.coli].
Jiang XF; Guo XY; Wan LP
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):564-7. PubMed ID: 16948895
[TBL] [Abstract][Full Text] [Related]
63. [Construction and prokaryotic expression of recombinant gene EGFRvIII HBcAg and immunogenicity analysis of the fusion protein].
Duan XY; Wang JS; Guo YM; Han JL; Wang QY; Yang GX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):21-4. PubMed ID: 17210099
[TBL] [Abstract][Full Text] [Related]
64. [The construction and expression of superantigen SEA and antimelanoma ScFv fusion gene].
Sun J; Lü AG; Wu WF; Bai XY; Ren XB; Liu H
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):750-3. PubMed ID: 15971592
[TBL] [Abstract][Full Text] [Related]
65. A favorable solubility partner for the recombinant expression of streptavidin.
Sørensen HP; Sperling-Petersen HU; Mortensen KK
Protein Expr Purif; 2003 Dec; 32(2):252-9. PubMed ID: 14965771
[TBL] [Abstract][Full Text] [Related]
66. Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF-NGR using multi-modal imaging.
Persigehl T; Ring J; Bremer C; Heindel W; Holtmeier R; Stypmann J; Claesener M; Hermann S; Schäfers M; Zerbst C; Schliemann C; Mesters RM; Berdel WE; Schwöppe C
Angiogenesis; 2014 Jan; 17(1):235-46. PubMed ID: 24136410
[TBL] [Abstract][Full Text] [Related]
67. Cloning of the SAP6 gene of Metschnikowia reukaufii and its heterologous expression and characterization in Escherichia coli.
Li J; Chi Z; Wang X
Microbiol Res; 2010 Mar; 165(3):173-82. PubMed ID: 18951000
[TBL] [Abstract][Full Text] [Related]
68. Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature.
Kessler T; Bieker R; Padró T; Schwöppe C; Persigehl T; Bremer C; Kreuter M; Berdel WE; Mesters RM
Clin Cancer Res; 2005 Sep; 11(17):6317-24. PubMed ID: 16144936
[TBL] [Abstract][Full Text] [Related]
69. [Construction and expression of the fusion gene CCK39/UreB in recombinant Escherichia coli BL-21(DE3)].
Zhang W; Li Y; Wu T; Luo W; Hu B; Hu W
Sheng Wu Gong Cheng Xue Bao; 2009 Jan; 25(1):37-42. PubMed ID: 19441224
[TBL] [Abstract][Full Text] [Related]
70. [Prokaryotic expression of F10 and preparation of its polyclonal antibody].
Fu X; Zou DT; Zhou WQ; Xing FQ; Li B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Sep; 23(9):856-8. PubMed ID: 17825236
[TBL] [Abstract][Full Text] [Related]
71. A plasmid expression system for quantitative in vivo biotinylation of thioredoxin fusion proteins in Escherichia coli.
Smith PA; Tripp BC; DiBlasio-Smith EA; Lu Z; LaVallie ER; McCoy JM
Nucleic Acids Res; 1998 Mar; 26(6):1414-20. PubMed ID: 9490786
[TBL] [Abstract][Full Text] [Related]
72. Genetic engineering of streptavidin, a versatile affinity tag.
Sano T; Vajda S; Cantor CR
J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(1):85-91. PubMed ID: 9792500
[TBL] [Abstract][Full Text] [Related]
73. pHLIP-mediated targeting of truncated tissue factor to tumor vessels causes vascular occlusion and impairs tumor growth.
Li S; Tian Y; Zhao Y; Zhang Y; Su S; Wang J; Wu M; Shi Q; Anderson GJ; Thomsen J; Zhao R; Ji T; Wang J; Nie G
Oncotarget; 2015 Sep; 6(27):23523-32. PubMed ID: 26143637
[TBL] [Abstract][Full Text] [Related]
74. High-level expression and purification of human epidermal growth factor with SUMO fusion in Escherichia coli.
Su Z; Huang Y; Zhou Q; Wu Z; Wu X; Zheng Q; Ding C; Li X
Protein Pept Lett; 2006; 13(8):785-92. PubMed ID: 17073723
[TBL] [Abstract][Full Text] [Related]
75. CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer.
Schmidt LH; Stucke-Ring J; Brand C; Schliemann C; Harrach S; Muley T; Herpel E; Kessler T; Mohr M; Görlich D; Kreuter M; Lenz G; Wardelmann E; Thomas M; Berdel WE; Schwöppe C; Hartmann W
Lung Cancer; 2017 Nov; 113():121-127. PubMed ID: 29110838
[TBL] [Abstract][Full Text] [Related]
76. [Soluble expression, purification and characterization of Bm K IT in Escherichia coli by intein-mediated system].
Xu CG; Fan XJ; Zhang ZY; Fu YJ; Liang AH
Sheng Wu Gong Cheng Xue Bao; 2007 Nov; 23(6):989-94. PubMed ID: 18257224
[TBL] [Abstract][Full Text] [Related]
77. Recombinant expression, purification and characterization of acetylated LysargiNase from Escherichia coli with high activity and stability.
Zhang J; Zhao M; Xiao W; Chang L; Wang F; Xu P
Rapid Commun Mass Spectrom; 2019 Jun; 33(12):1067-1075. PubMed ID: 30900783
[TBL] [Abstract][Full Text] [Related]
78. Overexpression of hTFF2 in the pET system and its in vitro pharmacological characterization.
Sun Y; Wu W; Wang L; Liang G; Zhang Y; Lv S; Wang Z; Wang S; Peng X
Biomed Pharmacother; 2010 May; 64(5):343-7. PubMed ID: 20074900
[TBL] [Abstract][Full Text] [Related]
79. Stable, high-affinity streptavidin monomer for protein labeling and monovalent biotin detection.
Lim KH; Huang H; Pralle A; Park S
Biotechnol Bioeng; 2013 Jan; 110(1):57-67. PubMed ID: 22806584
[TBL] [Abstract][Full Text] [Related]
80. In-silico design, expression, and purification of novel chimeric Escherichia coli O157:H7 OmpA fused to LTB protein in Escherichia coli.
Novinrooz A; Zahraei Salehi T; Firouzi R; Arabshahi S; Derakhshandeh A
PLoS One; 2017; 12(3):e0173761. PubMed ID: 28296951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
